

KETOPROFENE VIATRIS LP 100 mg, scored tablet with extended release 20 tablets
Active ingredients: KÉTOPROFÈNE
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet with extended release20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KETOPROFENE VIATRIS LP 100 mg, comprimé sécable à libération prolongée
- Pharmaceutical form
- comprimé sécable à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 20 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 May 2013
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60870244CIP72661869CIP133400926618698Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| KÉTOPROFÈNEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: KETOPROFENE 100 mg - BI PROFENID LP 100 mg, comprimé sécable à libération prolongée.







